Hi Bonneylad. Could be as soon as next week, or next month. Certain to be in the next quarter to avoid another CR. BB seems sure LBT won't run out of cash despite the tight numbers in the last Quarterly. Only 2 ways likely that will happen:
1. Cash flow and market confidence following a Collaboration Agreement with Leading Pharma to develop APAS Pharma, or
2. Announcement from Thermo Fisher/LBT re APAS Micro development by Collaboration.
Collaboration is not new to LBT. Previ Isola was commercialised by Collaboration with bioMerieux back in 2008. That deal made this company.
GLTAH
Ann: Updated Product Pipeline Strategy Announced, page-17
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.001(3.23%) |
Mkt cap ! $27.98M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.6¢ | 1.6¢ | $31.62K | 1.976M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1847724 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 1063750 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| LBT (ASX) Chart |